Literature DB >> 106307

[Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].

N Brock, J Stekar, J Pohl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106307     DOI: 10.1007/bf00369371

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


× No keyword cloud information.
  4 in total

1.  Cyclophosphamide and urinary bladder toxicity.

Authors:  F S PHILIPS; S S STERNBERG; A P CRONIN; P M VIDAL
Journal:  Cancer Res       Date:  1961-12       Impact factor: 12.701

2.  Unexpected toxicity in patients treated with iphosphamide.

Authors:  J J Van Dyk; H C Falkson; A M Van der Merwe; G Falkson
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

Review 3.  Protection against the toxicity of alkylating agents by thiols: the mechanism of protection and its relevance to cancer chemotherapy. A review.

Authors:  T A Connors
Journal:  Eur J Cancer       Date:  1966-12       Impact factor: 9.162

4.  Amelioration of cyclophosphamide-induced cystitis.

Authors:  A Primack
Journal:  J Natl Cancer Inst       Date:  1971-07       Impact factor: 13.506

  4 in total
  3 in total

1.  VP 16 plus ifosfamide plus cisplatin as salvage therapy in refractory testicular cancer.

Authors:  L H Einhorn
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.

Authors:  G Falkson; J J Van Dyk; R Stapelberg; H C Falkson
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols.

Authors:  N Brock; P Hilgard; J Pohl; K Ormstad; S Orrenius
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.